CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesity

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Vida, Margarita ^a,c   Rivera, Patricia ^a,c   Gavito, Ana Luisa ^a,c   Suárez, Juan ^a,c   Pavón, Francisco Javier ^a,c   Arrabal, Sergio ^a,c   Romero Cuevas, Miguel ^a,c   Bautista, Dolores ^a   Martínez, Ana ^b   Rodríguez De Fonseca, Fernando ^a,c   Serrano, Antonia ^a,c   Baixeras, Elena ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; FATTY ACID SYNTHASE; LIVER X RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; STEROL REGULATORY ELEMENT BINDING PROTEIN; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TRANSCRIPTION FACTOR;

ACACA GENE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CHREBP GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FASN GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; LIPOGENESIS; LXR ALPHA GENE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PERIRENAL ADIPOSE TISSUE; RAT; RECEPTOR BLOCKING; SCD1 GENE; SIGNAL TRANSDUCTION; SREBF 1 GENE; UPREGULATION; ANIMAL; BODY WEIGHT; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; KIDNEY; LIPID DIET; METABOLISM; PATHOLOGY; TIME; WHITE ADIPOSE TISSUE; WISTAR RAT;

ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DOWN-REGULATION; KIDNEY; LIPOGENESIS; MALE; OBESITY; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84896141301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090016     Document Type: Article

References (54)

1. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54; 254-260. (Pubitemid 12006594)
2. Cinti S (1999) The Adipose Organ. Milan, Italy: Kurtiss.
3. Miyashita Y, Koide N, Ohtsuka M, Ozaki H, Itoh Y, et al. (2004) Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract 65: 235-241. (Pubitemid 39141179)
4. Sasakabe T, Haimoto H, Umegaki H, Wakai K (2011) Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes. Diabetes Metab Syndr Obes 4: 167-174.
5. Strable M S, Ntambi JM (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 45: 199-214.
6. Cha JY, Repa JJ (2007) The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282: 743-751.
7. Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, et al. (2008) Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 20: 843-854.
8. Minehira K, Vega N, Vidal H, Acheson K, Tappy L (2004) Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord 28: 1291-1298. (Pubitemid 39389587)
9. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M (2002) Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 282: E46-51. (Pubitemid 34654105)
10. Ortega FJ, Mayas D, Moreno-Navarrete JM, Catalan V, Gomez-Ambrosi J, et al. (2009) The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 18: 13-20.
11. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556. (Pubitemid 38766330)
12. Pagano C, Rossato M, Vettor R (2008) Endocannabinoids, adipose tissue and lipid metabolism. J Neuroendocrinol 20 Suppl 1, 124-129. (Pubitemid 351559285)
13. Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, et al. (2004) Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol 160: 741-749. (Pubitemid 39362211)
14. Carr MC, Brunzell JD (2004) Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89: 2601-2607. (Pubitemid 38766338)
15. Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S (2005) Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 54: 770-777. (Pubitemid 40322081)
16. Britton KA, Fox CS (2011) Perivascular adipose tissue and vascular disease. Clin Lipidol 6: 79-91.
17. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431. (Pubitemid 38063771)
18. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R (2006) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73-100. (Pubitemid 43228239)
19. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060. (Pubitemid 44923642)
20. Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143: 315-317. (Pubitemid 29204987)
21. Kirkham TC (2005) Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16: 297-313.
22. Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, and Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40: 2-14.
23. Crespillo A, Suárez J, Bermudez-Silva FJ, Rivera P, Vida M, et al. (2010) Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade. Biochem J 433: 175-185.
24. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305. (Pubitemid 40629049)
25. Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118: 3160-3169.
26. Osei-Hyiaman D, Harvey-White J, Batkai S, Kunos G (2006) The role of the endocannabinoid system in the control of energy homeostasis. Int J Obes (Lond) 30 Suppl 1, S33-38.
27. Wu HM, Yang YM, Kim SG (2011) Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Galpha i/o inhibition. Mol Pharmacol 80: 859-869.
28. Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, et al (2013) Metabolic effects of chronic cannabis smoking. Diabetes Care 36: 2415-2422.
29. Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol, (168): 53-79.
30. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174. (Pubitemid 32995375)
31. Yap F, Craddock L, Yang J (2011) Mechanism of AMPK suppression of LXRdependent Srebp-1c transcription. Int J Biol Sci 7: 645-650.
32. Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG (2009) Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology 49: 1913-1925.
33. Uyeda K, Yamashita H, Kawaguchi T (2002) Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 63: 2075-2080. (Pubitemid 34756672)
34. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K (2001) Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 98: 13710-13715. (Pubitemid 33115963)
35. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B et al. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312: (Pt 2) 637-641. (Pubitemid 26002235)
36. Bost F, Aouadi M, Caron L, Binetruy B (2005) The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87: 51-56. (Pubitemid 40298765)
37. Kotzka J, Knebel B, Haas J, Kremer L, Jacob S, et al. (2012) Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity. PLoS One 7, e32609.
38. Lan R, Liu Q, Fan P, Lin S, Fernando SR, et al. (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42: 769-776. (Pubitemid 29110792)
39. Zhao S, Fernald RD (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12: 1047-1064. (Pubitemid 41580022)
40. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8. R19.
41. Chambers AP, Sharkey KA, Koopmans HS (2004) Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. Physiol Behav 82: 863-869. (Pubitemid 39297082)
42. Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, et al. (2007) Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282: 11687-11695. (Pubitemid 47100691)
43. Sipe JC, Scott TM, Murray S, Harismendy O, Simon GM, et al. (2010) Biomarkers of endocannabinoid system activation in severe obesity. PLoS One 5, e8792.
44. Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, et al. (2008) Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets. Mol Cell Endocrinol 286: S66-78.
45. Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, et al. (2008) Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16: 553-565. (Pubitemid 351328005)
46. Engeli S (2008) Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade. Obes Facts 1: 8-15.
47. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415-445.
48. Zelcer N, Tontonoz P (2006) Liver X Receptors as integrators of metabolic and inflammatory signaling. The J. Clin Invest 116: 607-614. (Pubitemid 43326865)
49. Yu R, Kim CS, Kwon BS, Kawada T (2006) Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 14: 1353-1362. (Pubitemid 46219660)
50. Chascione C, Elwyn DH, Davila M, Gil KM, Askanazi J, Kinney JM (1987) Effect of carbohydrate intake on de novo lipogenesis in human adipose tissue. Am J Physiol 253: E664-669.
51. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD (2000) The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A 97: 11371-11376.
52. Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, et al. (2000) Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 41: 99-108. (Pubitemid 30051847)
53. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, et al. (2000) MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275: 33302-33307.
54. Greenberg AS, Shen WJ, Muliro K, Patel S, Souza SC, et al. (2001) Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276: 45456-45461.